Gastroesophageal Junction Carcinoma

• CLINICAL_TRIALS trial_result · 2026-07-22
  Clinical Trial Update: Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975) [Phase 3]

  Phase 3 trial examining pembrolizumab plus chemoradiation versus placebo in esophageal cancer has completed.

• CLINICAL_TRIALS trial_result · 2025-11-05
  Clinical Trial Update: A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer [Phase 2]

  Phase II trial evaluating the effect of itraconazole on pathologic complete response rates in resectable esophageal cancer is currently recr…

• CLINICAL_TRIALS trial_result · 2025-02-10
  Clinical Trial Update: A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer [Phase 1]

  Seagen's SEA-TGT (SGN-TGT) Phase 1 safety study in advanced cancers has been terminated. The study enrolled patients across multiple cancer …